Protara Therapeutics, Inc. (TARA)
3.74
-0.04
(-1.06%)
USD |
NASDAQ |
Jun 11, 11:08
Protara Therapeutics Accounts Payable (Quarterly) : 4.031M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.031M |
| December 31, 2025 | 3.468M |
| September 30, 2025 | 4.504M |
| June 30, 2025 | 5.299M |
| March 31, 2025 | 2.31M |
| December 31, 2024 | 4.429M |
| September 30, 2024 | 2.295M |
| June 30, 2024 | 1.385M |
| March 31, 2024 | 0.972M |
| December 31, 2023 | 2.434M |
| September 30, 2023 | 2.504M |
| June 30, 2023 | 1.852M |
| March 31, 2023 | 4.081M |
| December 31, 2022 | 1.586M |
| September 30, 2022 | 0.456M |
| June 30, 2022 | 0.392M |
| March 31, 2022 | 0.541M |
| December 31, 2021 | 0.954M |
| September 30, 2021 | 0.928M |
| June 30, 2021 | 1.403M |
| March 31, 2021 | 1.853M |
| December 31, 2020 | 0.914M |
| September 30, 2020 | 1.913M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 2.650M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.716M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.06M |
| March 31, 2019 | 1.676M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.226M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 1.048M |
| June 30, 2014 | 0.994M |
| March 31, 2014 | 0.00 |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| NovelStem International Corp. | 0.00 |
| Brainstorm Cell Therapeutics, Inc. | 7.317M |
| Summit Therapeutics, Inc. | 27.55M |
| Kezar Life Sciences, Inc. | 0.273M |
| Clene, Inc. | 1.309M |